Skip to content

Itraconazole

Onmel, Sporanox, Tolsura (itraconazole) is a small molecule pharmaceutical. Itraconazole was first approved as Onmel on 1992-09-11. It is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, and coccidioidomycosis amongst others in the USA. Sporanox's patents are valid until 2033-06-21 (FDA).
Trade Name Onmel, Sporanox, Tolsura
Common Name Itraconazole
Indication aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, coccidioidomycosis, cryptococcosis, histoplasmosis, leishmaniasis, mycoses, neutropenia, onychomycosis, oral candidiasis, paracoccidioidomycosis, sporotrichosis, vulvovaginal candidiasis, zygomycosis
Drug Class Systemic antifungals (miconazole type)
Itraconazole
Get full access now